SCHEMBL21214819

SCHEMBL21214819

CC(S)CCNC(=O)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ ANPEP P15144 1/20 0.39
▸ DNPEP Q9ULA0 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ USP2 O75604 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ LAP3 P28838 1/20 0.37
▸ MEN1 O00255 3/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNB4 P30926 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11129 0.81 ANPEP (0.55) KMT2ACYP2C19CYP2D6CYP2C9ANPEP
SCHEMBL12131751 0.80 USP2 (0.55) KMT2ACYP2C19CYP2D6CYP2C9ANPEP
SCHEMBL20687626 0.79 ALDH1A1 (0.50) KMT2ACYP2C19CYP2D6CYP2C9ANPEP
SCHEMBL146289 0.78 — —
SCHEMBL23788919 0.77 KMT2A (0.42) KMT2ACYP2C19CYP2D6CYP2C9ANPEP
SCHEMBL21214691 0.77 KMT2A (0.42) KMT2ACYP2C19CYP2D6CYP2C9ANPEP
SCHEMBL25914484 0.77 KMT2A (0.42) KMT2ACYP2C19CYP2D6CYP2C9ALDH1A1
SCHEMBL8749749 0.76 — —
SCHEMBL20810611 0.76 USP2 (0.46) KMT2ACYP2C19CYP2D6CYP2C9ANPEP
SCHEMBL22548464 0.76 USP2 (0.46) KMT2ACYP2C19CYP2D6CYP2C9ANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019147862-A1 CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF FLX BIO, INC. (US) 2019-08-01 — — WO disclosed
Send feedback